These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 1281393

  • 1. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
    Wondimu Z, Sönnerborg A, Ayehunie S, Britton S, Strannegård O.
    Antiviral Res; 1992 Oct 01; 19(4):353-9. PubMed ID: 1281393
    [Abstract] [Full Text] [Related]

  • 2. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
    Ayehunie S, Sönnerborg A, Desta B, Kefene H, Zewdie D, Britton S, Strannegård O.
    AIDS; 1992 Jul 01; 6(7):651-7. PubMed ID: 1503684
    [Abstract] [Full Text] [Related]

  • 3. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
    St Clair MH, Martin JL, Tudor-Williams G, Bach MC, Vavro CL, King DM, Kellam P, Kemp SD, Larder BA.
    Science; 1991 Sep 27; 253(5027):1557-9. PubMed ID: 1716788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
    Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA.
    J Virol; 1992 Dec 27; 66(12):7128-35. PubMed ID: 1279198
    [Abstract] [Full Text] [Related]

  • 11. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q, Parniak MA, Gu Z, Wainberg MA.
    Leukemia; 1992 Dec 27; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [Abstract] [Full Text] [Related]

  • 12. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL, Ahmed PS, Tyms AS, Wood LJ, Kelly LA, Chambers P, Clarke J, Bedard J, Bowlin TL, Rando RF.
    Antivir Chem Chemother; 2000 Jul 27; 11(4):291-301. PubMed ID: 10950391
    [Abstract] [Full Text] [Related]

  • 13. [Investigation of AZT susceptibility of sequential HIV-1 isolates from patients treated with ddI after long-term therapy with AZT].
    Saito T, Kondo M, Ito A, Nagao T, Hayashi T, Watanabe S, Imai M.
    Kansenshogaku Zasshi; 1994 Jul 27; 68(7):819-23. PubMed ID: 8089546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP, Nandy P, Avramis VI.
    In Vivo; 2000 Jul 27; 14(3):377-88. PubMed ID: 10904870
    [Abstract] [Full Text] [Related]

  • 17. In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine.
    Bazmi HZ, Hammond JL, Cavalcanti SC, Chu CK, Schinazi RF, Mellors JW.
    Antimicrob Agents Chemother; 2000 Jul 27; 44(7):1783-8. PubMed ID: 10858331
    [Abstract] [Full Text] [Related]

  • 18. Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
    Medina DJ, Hsiung GD, Mellors JW.
    Antimicrob Agents Chemother; 1992 May 27; 36(5):1127-30. PubMed ID: 1510405
    [Abstract] [Full Text] [Related]

  • 19. Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1.
    Gao Q, Gu Z, Salomon H, Nagai K, Parniak MA, Wainberg MA.
    Arch Virol; 1994 May 27; 136(1-2):111-22. PubMed ID: 8002779
    [Abstract] [Full Text] [Related]

  • 20. Natural resistance of human immunodeficiency virus type 2 to zidovudine.
    Reid P, MacInnes H, Cong ME, Heneine W, García-Lerma JG.
    Virology; 2005 Jun 05; 336(2):251-64. PubMed ID: 15892966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.